Sign in

David Berkman

Director at Hamilton LaneHamilton Lane
Board

About David J. Berkman

David J. Berkman is an independent director of Hamilton Lane Incorporated (HLNE), serving since May 2017; he is age 63 as of the July 9, 2025 record date and holds a B.S. in Economics from the Wharton School of the University of Pennsylvania . He serves on HLNE’s Audit Committee and Compensation Committee and has been determined independent under Nasdaq rules; the board has also determined that each Audit Committee member, including Berkman, qualifies as an “audit committee financial expert” . HLNE’s board held nine meetings in fiscal 2025; each director attended at least 75% of the aggregate meetings and committees except Messrs. Sexton and Giannini, indicating Berkman met the threshold .

Past Roles

OrganizationRoleTenureCommittees/Impact
Audacy, Inc. (OTC: AUDAQ)Director; Audit & Compensation Committees (Chair of Compensation)Served until 2024Governance oversight in media; committee chair experience
Rotor Acquisition Corp.DirectorServed until 2021SPAC board experience
University of Pennsylvania School of Engineering and Applied ScienceBoard of OverseersServed until 2022Academic oversight
WatchBanQ Group LimitedDirectorServed until 2024Board service (company status not detailed in proxy)

External Roles

OrganizationRoleTenureCommittees/Impact
Associated Partners, LPManaging PartnerSince January 2000Telecommunications infrastructure investing/operations leadership
Decibel Group, LLC (family office)Managing PartnerSince January 2020Family office leadership
Chemimage, Inc.Director; Compensation CommitteeCurrentPrivate company governance; compensation oversight
First Round CapitalAdvisory Committee MemberCurrentVenture advisory role

Board Governance

  • Independence: Board determined Berkman is “independent” under Nasdaq rules; Audit Committee members (Varon, Berkman, Sexton) meet Rule 10A-3 independence and “audit committee financial expert” criteria .
  • Committees: Audit Committee (member); Compensation Committee (member). Audit Committee held eight meetings in fiscal 2025; Compensation Committee held three meetings .
  • Attendance: Board met nine times in fiscal 2025; each director attended ≥75% of board and committee meetings except Sexton and Giannini (Berkman met threshold) .
  • Controlled company: HLNE is a “controlled company” under Nasdaq rules and is exempt from majority-independent board and fully independent compensation committee requirements; executives serve on the Compensation Committee (Rogers, Giannini), alongside independent directors (including Berkman) .
  • Independent sessions and leadership: Independent directors meet without management; board leadership separated between Executive Co-Chairman and Co-CEOs; independent director participation emphasized .

Fixed Compensation

HLNE director compensation policy provides a $200,000 annual retainer (electable as cash, restricted stock, or combination) and an additional $35,000 annual cash retainer for the Audit Committee Chair (not applicable to Berkman); no meeting fees are paid . In fiscal 2024, the annual director retainer was raised by $25,000 and the Audit Chair retainer by $20,000; Berkman elected cash only in both fiscal 2024 and fiscal 2025 .

MetricFY 2024FY 2025
Director Annual Retainer (Cash)$188,542 $200,000
Audit Committee Chair Additional Retainer$35,000 (structure; not received by Berkman) $35,000 (structure; not received by Berkman)
Meeting Fees$0 $0
Total Director Compensation (Berkman)$188,542 $200,000

Performance Compensation

  • Stock awards: HLNE’s non-employee directors may elect time-based restricted stock vesting one year after grant; Berkman received no stock awards in fiscal 2024 or fiscal 2025 .
  • Options/PSUs: HLNE does not currently grant stock options to directors; director equity is time-based restricted stock only (if elected) .
  • Performance metrics: None apply to director compensation; director equity, when elected, is time-based (no performance conditions) .
MetricFY 2024FY 2025
Stock Awards (Grant-Date Fair Value)$0 $0
Equity Vesting Schedule1-year time-based (policy) 1-year time-based (policy)

Other Directorships & Interlocks

Company/EntityPublic/PrivateRoleOverlap/Interlock Risk
Audacy, Inc. (OTC: AUDAQ)PublicDirector; Committee ChairNo HLNE customer/supplier ties disclosed; no related-party transactions disclosed
Chemimage, Inc.PrivateDirector; Compensation CommitteeNo HLNE related-party transactions disclosed
WatchBanQ Group LimitedNot specifiedDirector (until 2024)No HLNE related-party transactions disclosed
Rotor Acquisition Corp.Public (SPAC, historical)Director (until 2021)No HLNE related-party transactions disclosed
First Round CapitalPrivate (VC)Advisory CommitteeNo HLNE related-party transactions disclosed

Expertise & Qualifications

  • Financial expertise: Audit Committee member; board determined Audit Committee members, including Berkman, qualify as “audit committee financial experts” .
  • Industry/operational experience: Managing Partner at Associated Partners (telecom infrastructure) and Decibel Group (family office), bringing investment, operations, corporate finance, reporting, and controls insight to HLNE .
  • Education: B.S. in Economics, Wharton School (University of Pennsylvania) .

Equity Ownership

  • Beneficial ownership: Berkman beneficially owns 25,000 shares of Class A common stock; represents less than 1% of Class A outstanding .
  • Vested vs. unvested: As of March 31, 2025, Berkman had no restricted stock outstanding (i.e., no unvested director equity) .
  • Pledging/hedging: Company policy prohibits directors from hedging or pledging HLNE securities .
Ownership MetricValue
Class A Shares Beneficially Owned25,000; <1% of Class A outstanding
Restricted Stock Outstanding (Unvested)0
Options OutstandingNone disclosed for directors
Hedging/Pledging StatusProhibited by company policy

Governance Assessment

  • Positives: Independent director with audit committee financial expert status and dual committee service (Audit, Compensation), meeting attendance thresholds in fiscal 2025 . No related-party transactions disclosed involving Berkman; he is not listed among directors and executives who invested in HLNE-managed funds during April 1, 2024–July 1, 2025, reducing potential conflicts via preferential economics (investors listed did not include Berkman) .
  • Shareholder signals: Strong say-on-pay support—94.9% approval at 2024 annual meeting (management cites continuity of policies), and 2025 vote totaled 98,253,133 “for,” 30,764,307 “against,” 12,397 “abstentions” (board affirmed annual frequency) .
  • RED FLAGS: Controlled company status and Compensation Committee composition include executives (Rogers, Giannini) alongside independent members (including Berkman), reducing full independence of pay oversight; however, structure is permitted under Nasdaq’s controlled company exemptions . Concentrated voting power: HLA Investments, LLC (HLAI) held ~51% of aggregate voting power as of 2025 record date, with voting group collectively ~75%, effectively determining outcomes; Berkman’s influence may be constrained by control dynamics .

Director Compensation Committee Analysis

  • Composition: Compensation Committee comprises Rogers (Chair), Giannini, Berkman, Sexton, and Varon; executives (Rogers, Giannini) are current officers, with committee majority including independent members .
  • Consultant independence: Semler Brossy advised on executive compensation; Compensation Committee assessed consultant independence and found no conflicts .
  • Policy safeguards: Clawback policy compliant with SEC/Nasdaq; insider trading policy prohibits hedging/pledging; equity grant practices avoid timing near MNPI releases and require FMV pricing for options (though options are not currently granted) .

Related-Party Transactions (Conflict Review)

  • Approval framework: Audit Committee reviews/approves related-party transactions >$120,000; committee oversees ongoing monitoring .
  • Disclosures: Proxy details several related-party agreements and governance of exchanges/tax receivable agreements, but no transactions specifically involving Berkman are disclosed . Director/executive personal investments in HLNE funds were disclosed for certain individuals and ratified when pre-approvals were missing; Berkman was not among those named in the investment list for the period reviewed .